Frazor Edmondson
Vermögen: 538 587 $ am 31.05.2026
Vermögen: 538 587 $ am 31.05.2026
Frazor Titus Edmondson currently works at Zai Lab Ltd., as Secretary & Chief Legal Officer from 2025.
Mr. Edmondson also formerly worked at Sumitomo Pharma America, Inc., as Secretary, Associate General Counsel & VP and Biogen, Inc., as Chief Corporation Counsel & Senior Vice President from 2014 to 2020.
Mr. Edmondson received his undergraduate degree in 1988 from Washington & Lee University and graduate degree in 1993 from Widener University School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZAI LAB LTD. 0,03 % | 26.06.2026 | 303 460 ( 0,03 % ) | 538 587 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ZAI LAB LIMITED | General Counsel | 07.08.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.08.2020 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Unternehmenssekretär | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Washington & Lee University
Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Widener University School of Law
Widener University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen